Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and he...
Jan 7, 2026, 10:40 AM EST - 27 days ago
Dec 29, 2025, 9:54 PM EST - 5 weeks ago
Dec 4, 2025, 8:42 AM EST - 2 months ago
Nov 26, 2025, 2:44 AM EST - 2 months ago
Nov 14, 2025, 8:00 AM EST - 2 months ago
Sep 2, 2025, 8:00 AM EDT - 5 months ago
May 12, 2025, 8:00 AM EDT - 9 months ago
Mar 31, 2025, 8:00 AM EDT - 11 months ago
Jan 10, 2025, 8:00 AM EST - 1 year ago
Dec 20, 2024, 10:29 AM EST - 1 year ago
Dec 20, 2024, 8:00 AM EST - 1 year ago
Nov 18, 2024, 8:00 AM EST - 1 year ago
Nov 14, 2024, 8:00 AM EST - 1 year ago
Oct 15, 2024, 8:00 AM EDT - 1 year ago
Sep 3, 2024, 8:30 AM EDT - 1 year ago
Aug 13, 2024, 8:00 AM EDT - 1 year ago
Aug 1, 2024, 8:00 AM EDT - 1 year ago
Jun 4, 2024, 8:00 AM EDT - 1 year ago
May 15, 2024, 8:00 AM EDT - 1 year ago
Mar 29, 2024, 8:00 AM EDT - 2 years ago
Mar 20, 2024, 8:11 PM EDT - 2 years ago
Mar 12, 2024, 8:00 AM EDT - 2 years ago
Dec 7, 2023, 6:00 AM EST - 2 years ago
Nov 13, 2023, 8:45 AM EST - 2 years ago
Nov 13, 2023, 8:00 AM EST - 2 years ago
Nov 3, 2023, 8:00 AM EDT - 2 years ago
Oct 23, 2023, 8:00 AM EDT - 2 years ago
Oct 12, 2023, 8:00 AM EDT - 2 years ago
Sep 26, 2023, 8:00 AM EDT - 2 years ago
Sep 14, 2023, 8:15 AM EDT - 2 years ago
GLTO
Sep 13, 2023, 5:22 PM EDT - 2 years ago
Sep 7, 2023, 12:00 PM EDT - 2 years ago
Aug 14, 2023, 8:00 AM EDT - 2 years ago
May 15, 2023, 8:00 AM EDT - 2 years ago
Apr 27, 2023, 8:00 AM EDT - 3 years ago
Apr 18, 2023, 8:00 AM EDT - 3 years ago
Mar 30, 2023, 8:00 AM EDT - 3 years ago
Mar 16, 2023, 8:00 AM EDT - 3 years ago
Jan 24, 2023, 8:00 AM EST - 3 years ago
Jan 5, 2023, 8:00 AM EST - 3 years ago
Nov 28, 2022, 8:00 AM EST - 3 years ago
Nov 14, 2022, 8:00 AM EST - 3 years ago
Nov 1, 2022, 8:00 AM EDT - 3 years ago
Oct 14, 2022, 8:00 AM EDT - 3 years ago
Oct 12, 2022, 8:00 AM EDT - 3 years ago